Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Clinical trial NCT00763321 · COMPLETED

Trial details

NCT number: NCT00763321
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Low Back Pain

Start date: 2008-09-01
Primary completion: 2009-04-01
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.